ロード中...
TRAIL and IFNα act synergistically to induce renal cell carcinoma apoptosis
INTRODUCTION: Despite modern targeted therapy, metastatic renal cell carcinoma (RCC) remains a deadly disease. Interferon alpha (IFNα) is currently used to treat this condition, mainly in combination with the targeted anti-VEGF antibody, bevacizumab. Apo2 ligand/Tumor necrosis factor related apoptos...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2963111/ https://ncbi.nlm.nih.gov/pubmed/20663526 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2010.04.064 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|